Astellas Pharma Inc.: U.S. FDA Approves Expanded Label for Astellas' IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
Theralase Technologies, Inc.: Theralase Releases Latest Research on Inactivation of Herpes Simplex Viruses
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...
Medscape5d
Assessment of Language Function in Dementia
Impairment in language is a common finding among individuals with dementia and can be a presenting symptom, particularly in Alzheimer's dementia and primary progressive aphasia. Early recognition ...
moneycontrol.com6d
Becton, Dickinson and Co.
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
ushmm.org3d
Origins of Neo-Nazi and White Supremacist Terms and Symbols
The eruption of neo-Nazism and White Supremacy across the country has exposed the public to symbols, terms, and ideology drawn directly from Nazi Germany and Holocaust-era fascist movements. The ...
urologytimes1d
Prostate Cancer
The incidence of late grade 2 or greater GU toxicity at 5 years was 12.5% among those who did experience acute toxicity vs 7.5% among those who did not. “MPS2 could potentially improve the health of ...
MedPage Today3d
Second Opinions
Visit the MedPage Today Information Center to learn more about how you can contribute as a physician or other healthcare provider. Visit us on Facebook. Opens in a new tab or window Visit us on X ...